Cresco Labs Texas medical cannabis license rescinded after DPS tabulation correction

Colgate-Palmolive Company

Colgate-Palmolive Company

CL

0.00
  • Cresco Labs Texas conditional medical cannabis license under Texas Compassionate Use Program was rescinded after Texas Department of Public Safety retroactively corrected its tabulation methodology for selecting licensees.
  • Cresco unit was moved to TCUP eligibility list, leaving it to receive a license only if one of 12 newly selected conditional licensees fails state due diligence or does not become fully operational within 24 months of licensure under House Bill 46.
  • Company said it is evaluating options to work with Texas to protect original award determination, raising risk to timing and certainty of planned market entry.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cresco Labs Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605110630BIZWIRE_USPR_____20260511_BW242350) on May 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.